A phase 1/2 study of chemosensitization with plerixafor plus G-CSF in relapsed or refractory acute myeloid leukemia

BLOOD CANCER JOURNAL

NATURE PUBLISHING GROUP

1. National Cancer Institute at the National Institutes of Health [P30 CA91842]
2. Genzyme/Sanofi
3. National Institutes of Health grant [K23 CA140707, R01 CA152329, R21 CA141523, R21 CA132269]